News
Consumer demand for GLP-1 drugs like Ozempic and Wegovy has drawn a flood of new entrants. Yaccarino will have to find a way ...
The eMed Population Health digital health platform announced Tuesday that former X Chief Executive Officer Linda Yaccarino ...
Though Yaccarino does not have experience in health tech, eMed said in a press release that they sought her out for her ...
Yaccarino has been named CEO of Miami-based eMed Population Health, which calls itself “the leading digital health platform ...
The choice reflects the company's aims to revolutionize chronic care and expand global health solutions through innovative ...
Linda Yaccarino, the former X CEO who left the social media company in the wake of yet another Elon Musk controversy, has ...
Just a month after her exit from Musk's X, the tech executive will lead the digital platform for GLP-1 health management ...
(Reuters) - Digital health platform eMed Population Health said on Tuesday it has appointed Linda Yaccarino, the former CEO ...
EMED Assembles Top Scientific Advisory Board to Bolster Launch of Breakthrough Infusion Technologies
EMED Technologies, a global leader in drug delivery and innovative infusion therapy devices, announced the members of its Scientific Advisory Board (SAB). Established in 1991, EMED Technologies is a ...
Med Population Health, the leading digital health platform for GLP-1/GIP population health management, today announced the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results